why choose us

First received: July 21, 2024

Clinical Trial: Replication of the NefIgArd Trial of TRF-budesonide in Primary IgAN

Study Status: COMPLETED

Recruit Status: COMPLETED

Condition: Primary IgA Nephropathy

Study Type: OBSERVATIONAL


Official Title: Replication of the NefIgArd Trial of Effectiveness and Safety of a Targeted-release Formulation of Budesonide in Patients With Primary IgA Nephropathy

Brief Summary: This replication of the NefIgArd trial of TRF-budesonide aims to use real-world data to evaluate the efficiency and safety of TRF-budesonide in the treatment of IgA nephropathy, from completing real-world research to providing real-world evidence.

Read more